Rat and rabbit whole embryo culture as a new approach method for unlabeled therapeutic antisense oligonucleotide hazard identification with no requirement for microinjection or assisted transfection
Sara M Bender(GlaxoSmithKline (United States)), Dinesh Stanislaus(GlaxoSmithKline (United States)), Sharon Chapman(GlaxoSmithKline (United States)), Joel D. Parry(Age UK), Stanley Robinson(GlaxoSmithKline (United States)), Bradley Spencer-Dene(Age UK), Sreenivas Nannapaneni(GlaxoSmithKline (United States)), Joyce Rendemonti(GlaxoSmithKline (United States))
Cited by 0
Related Papers
RRM2 Regulates Bcl-2 in Head and Neck and Lung Cancers: A Potential Target for Cancer Therapy
|Clinical Cancer Research|2013|137
Doxorubicin In Vivo Rapidly Alters Expression and Translation of Myocardial Electron Transport Chain Genes, Leads to ATP Loss and Caspase 3 Activation
|PLoS ONE|2010|127
<i>In silico</i>and<i>in vitro</i>evaluation of exonic and intronic off-target effects form a critical element of therapeutic ASO gapmer optimization
|Nucleic Acids Research|2015|109
Assessing unintended hybridization-induced biological effects of oligonucleotides
|Nature Biotechnology|2012|108
Challenges for inhaled drug discovery and development: Induced alveolar macrophage responses
|Advanced Drug Delivery Reviews|2014|91